000 | 00894 a2200277 4500 | ||
---|---|---|---|
005 | 20250517140613.0 | ||
264 | 0 | _c20170221 | |
008 | 201702s 0 0 eng d | ||
022 | _a1533-4406 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenberg, Steven A | |
245 | 0 | 0 |
_aT-Cell Transfer Therapy Targeting Mutant KRAS. _h[electronic resource] |
260 |
_bThe New England journal of medicine _c02 2017 |
||
300 |
_ae11 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xtherapy |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aTran, Eric | |
700 | 1 | _aRobbins, Paul F | |
773 | 0 |
_tThe New England journal of medicine _gvol. 376 _gno. 7 _gp. e11 |
|
999 |
_c26882391 _d26882391 |